Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Veradermics, Incorporated(MANE) | 2,401,868 | 2,080,119 | -321,749 | $295.29M | $252.17M | 21.94% | -$43.11M |
| ADARx Pharmaceuticals, Inc. | 0 | 9,936,661 | +9,936,661 | $0 | $198.14M | 17.24% | +$198.14M |
| Zenas BioPharma, Inc.(ZBIO) | 5,037,854 | 5,037,854 | 0 | $127.86M | $135.87M | 11.82% | +$8.01M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 2,038,763 | 2,038,763 | 0 | $111.19M | $112.78M | 9.81% | +$1.59M |
| Avalyn Pharma, Inc | 3,308,649 | 3,308,649 | 0 | $108.92M | $94.26M | 8.20% | -$14.66M |
| Odyssey Therapeutics, Inc. | 3,794,883 | 3,794,883 | 0 | $71.00M | $84.32M | 7.34% | +$13.32M |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | $94.44M | $82.04M | 7.14% | -$12.40M |
| ORIC Pharmaceuticals, Inc. | 4,615,384 | 4,615,384 | 0 | $49.98M | $62.17M | 5.41% | +$12.18M |
| Mineralys Therapeutics, Inc.(MLYS) | 1,563,966 | 1,563,966 | 0 | $42.20M | $39.30M | 3.42% | -$2.89M |
| Korsana Biosciences, Inc. | 0 | 613,915 | +613,915 | $0 | $19.65M | 1.71% | +$19.65M |
| Mobia Medical, Inc | 1,986,072 | 1,986,072 | 0 | $26.61M | $18.77M | 1.63% | -$7.84M |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | $32.14M | $17.30M | 1.50% | -$14.85M |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $55.15M | $14.48M | 1.26% | -$40.67M |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | $9.43M | $8.73M | 0.76% | -$700.0K |
| Oculis Holding AG | 641,022 | 641,022 | 0 | $8.89M | $5.99M | 0.52% | -$2.90M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 137,753 | 137,753 | 0 | $4.60M | $2.07M | 0.18% | -$2.53M |
| enGene Therapeutics Inc. | 0 | 747,750 | +747,750 | $0 | $1.50M | 0.13% | +$1.50M |
| enGene Holdings Inc. COM | 747,750 | 0 | -747,750 | $1.29M | $0 | — | -$1.29M |